...
首页> 外文期刊>Antimicrobial agents and chemotherapy. >Haemophilus influenzae clinical isolates with plasmid pB1000 bearing blaROB-1: fitness cost and interspecies dissemination.
【24h】

Haemophilus influenzae clinical isolates with plasmid pB1000 bearing blaROB-1: fitness cost and interspecies dissemination.

机译:带有blaROB-1质粒pB1000的流感嗜血杆菌临床分离株:适应性成本和种间传播。

获取原文
获取原文并翻译 | 示例

摘要

Plasmid pB1000 is a mobilizable replicon bearing the bla(ROB-1) beta-lactamase gene that we have recently described in Haemophilus parasuis and Pasteurella multocida animal isolates. Here we report the presence of pB1000 and a derivative plasmid, pB1000', in four Haemophilus influenzae clinical isolates of human origin. Pulsed-field gel electrophoresis showed unrelated patterns in all strains, indicating that the existence of pB1000 in H. influenzae isolates is not the consequence of clonal dissemination. The replicon can be transferred both by transformation and by conjugation into H. influenzae, giving rise to recipients resistant to ampicillin and cefaclor (MICs, > or =64 microg/ml). Stability experiments showed that pB1000 is stable in H. influenzae without antimicrobial pressure for at least 60 generations. Competition experiments between isogenic H. influenzae strains with and without pB1000 revealed a competitive disadvantage of 9% per 10 generations for the transformant versus the recipient. The complete nucleotide sequences of nine pB1000 plasmids from human and animal isolates, as well as the epidemiological data, suggest that animal isolates belonging to the Pasteurellaceae act as an antimicrobial resistance reservoir for H. influenzae. Further, since P. multocida is the only member of this family that can colonize both humans and animals, we propose that P. multocida is the vehicle for the transport of pB1000 between animal- and human-adapted members of the Pasteurellaceae.
机译:质粒pB1000是一个带有bla(ROB-1)β-内酰胺酶基因的可动复制子,我们最近在副猪嗜血杆菌和多杀巴斯德氏菌动物分离物中描述了该基因。在这里,我们报告了人类起源的四个流感嗜血杆菌临床分离株中pB1000和衍生质粒pB1000'的存在。脉冲场凝胶电泳在所有菌株中均显示无关的模式,表明流感嗜血杆菌分离株中pB1000的存在不是克隆传播的结果。复制子既可以通过转化也可以通过缀合转移到流感嗜血杆菌中,从而产生对氨苄青霉素和头孢克洛(MIC,≥64μg/ ml)耐药的受体。稳定性实验表明,pB1000在流感嗜血杆菌中在没有抗菌压力的情况下至少可稳定60代。具有和不具有pB1000的同基因流感嗜血杆菌菌株之间的竞争实验显示,转化体与受体相比,竞争优势为每10代9%。来自人和动物分离株的9个pB1000质粒的完整核苷酸序列以及流行病学数据表明,属于巴斯德杆菌科的动物分离株可作为流感嗜血杆菌的抗药性储库。此外,由于多杀巴斯德氏菌是该家族中唯一可以同时在人类和动物中定殖的成员,我们建议多杀巴斯德氏菌是在动物和人类适应的巴斯德杆菌科之间转运pB1000的载体。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号